08:00 Wed 04 Oct 2017
OptiBiotix Health - Successful launch of products at Supply Side West
("OptiBiotix" or the "Company")
Successful launch of LPLDL® and SlimBiome® products at Supply Side West 2017
OptiBiotix Health plc (AIM:OPTI), a life sciences business developing compounds to tackle obesity,high cholesterol, and diabetes announces the successful launch of its SlimBiome® and LPLDL® products at Supply Side West in
The Company recently obtained
Both LPLDL® and SlimBiome® were extremely well received with high interest in the distribution and sale of these products from partners across
1. Sacco have appointed Dr
2. Cereal Ingredients have incorporated SlimBiome® into their range of cereal based particulates and speciality ingredients. This technical innovation extends the application of SlimBiome® into bakery products (e.g. cookies, cakes and tortillas), breakfast cereals (puffs and flakes), crackers, toppings (e.g. salad, breakfast) as well as increasing the range of options for healthy snacks, yoghurts and cereal bars. This significantly extends the scale of the opportunity beyond weight management into the nutraceutical, health and wellbeing industry sectors.
For further information, please contact:
|
||
|
Contact via Walbrook below |
|
|
|
|
|
Tel:020 7933 8780 or optibiotix@walbrookpr.com |
|
|
Mob: 07876 741 001 |
|
About OptiBiotix - www.optibiotix.com
OptiBiotix was formed in
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes.
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE